Barclays
MR

Barclays’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Barclays’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-143,200
Closed -$3.87M – 6774
2015
Q4 		$3.87M Sell
143,200
-2,300
-2% -$59.2K ﹤0.01% 1495
2015
Q3 		$3.06M Buy
145,500
+83,600
+135% +$2.13M ﹤0.01% 1757
2015
Q2 		$1.73M Buy
61,900
+58,100
+1,529% +$1.69M ﹤0.01% 2346
2015
Q1 		$103K Sell
3,800
-6,000
-61% -$165K ﹤0.01% 4834
2014
Q4 		$255K Buy
9,800
+400
+4% +$11.7K ﹤0.01% 4430
2014
Q3 		$282K Sell
9,400
-555,800
-98% -$17.2M ﹤0.01% 4441
2014
Q2 		$17.5M Sell
565,200
-20,700
-4% -$657K 0.02% 779
2014
Q1 		$18.7M Buy
585,900
+531,100
+969% +$18.6M 0.02% 736
2013
Q4 		$1.97M Sell
54,800
-60,000
-52% -$2.33M ﹤0.01% 2687
2013
Q3 		$4.36M Buy
114,800
+88,300
+333% +$3.56M 0.01% 1801
2013
Q2 		$992K Buy
+26,500
New +$1.05M ﹤0.01% 3366

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Barclays's MR Position: Q1 2016 in Review

Barclays sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 216,442 shares — an estimated $5.84M sold.

Barclays first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $14.5M in Q2 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Barclays reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 216,442 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $5.84M.
  • Barclays first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Barclays's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $14.5M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.